Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)

¹ The Agency is re­spons­ible for in­spec­tions car­ried out in Switzer­land sub­ject to the re­ser­va­tions of Art­icles 30 and 34 para­graph 4.

² It is re­spons­ible for the in­spec­tions spe­cified in Art­icles 6, 19 and 28 in the fol­low­ing sec­tors:

a.

im­mun­o­lo­gic­al medi­cin­al products;

b.

blood and blood products;

c.

rarely used pro­ced­ures which re­quire very spe­cif­ic and spe­cial­ised know­ledge.

³ It shall del­eg­ate the in­spec­tions re­ferred to in Art­icles 6, 19 and 28 in all oth­er sec­tors to the can­ton­al in­spect­or­ates in­so­far as they sat­is­fy the re­quire­ments of fed­er­al le­gis­la­tion and in­ter­na­tion­al law ap­plic­able in Switzer­land.

⁴ It may in­volve the can­ton­al in­spect­or­ates in, or ask them to carry out in­spec­tions with­in its area of com­pet­ence.

⁵ The can­tons may in­volve re­gion­al or oth­er can­ton­al in­spect­or­ates or the Agency in, or ask them to carry out the in­spec­tions re­ferred to in para­graph 3.